Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob B van der Luijt

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
BMC Medicine|November 16, 2016
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsJoanne M de Laat, Rob B van der Luijt, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutationsMarianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Familial Cancer|February 28, 2016
Difference in CXCR4 expression between sporadic and VHL-related hemangioblastomaRoeliene C Kruizinga, Denise M S van Marion, Wilfred F A den Dunnen, et al.
Familial Cancer|November 10, 2016
Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the NetherlandsCharlotte J Dommering, Lidewij Henneman, Annemarie H van der Hout, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasiaMarianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 19, 2011
Compliance with periodic surveillance for Von-Hippel-Lindau diseaseChantal R M Lammens, Neil K Aaronson, Frederik J Hes, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2015
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and ErythrocytosisEsther Korpershoek, Djamailys Koffy, Bert H Eussen, et al.
BMC Cancer|July 1, 2009
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an exampleLeila Mohammadi, Maaike P Vreeswijk, Rogier Oldenburg, et al.
Breast Cancer Research : BCR|February 10, 2009
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family historyEncarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
BMC Medicine|November 16, 2016
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsJoanne M de Laat, Rob B van der Luijt, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutationsMarianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Familial Cancer|February 28, 2016
Difference in CXCR4 expression between sporadic and VHL-related hemangioblastomaRoeliene C Kruizinga, Denise M S van Marion, Wilfred F A den Dunnen, et al.
Familial Cancer|November 10, 2016
Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the NetherlandsCharlotte J Dommering, Lidewij Henneman, Annemarie H van der Hout, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasiaMarianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 19, 2011
Compliance with periodic surveillance for Von-Hippel-Lindau diseaseChantal R M Lammens, Neil K Aaronson, Frederik J Hes, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2015
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and ErythrocytosisEsther Korpershoek, Djamailys Koffy, Bert H Eussen, et al.
BMC Cancer|July 1, 2009
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an exampleLeila Mohammadi, Maaike P Vreeswijk, Rogier Oldenburg, et al.
Breast Cancer Research : BCR|February 10, 2009
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family historyEncarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, et al.
Pageof 7